For 14-3-3γ to modulate the activity of LRRK2 and become a new strategy to treat Parkinson's disease, a better understanding of the functional network of 14-3-3γ and further research into the molecular processes of its interactions with key partners is required. This evidence concerns the gene LRRK2 and Parkinson disease.